Robert Sidonio/LinkedIn
Aug 9, 2025, 01:53
Robert Sidonio: VWF Inhibitors – A Family Affair
Robert Sidonio, Professor of Pediatrics at Emory University Hospital, shared an insightful post on LinkedIn:
”Thanks to Octapharma for organizing and to the lead author Claudia Djambas Khayat MD on this case report of VWF inhibitors. More research is needed on this topic.”
Read the full article here.
Article: von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
Authors: Claudia Djambas Khayat, Anna Pavlova, Sylvia Werner, Sigurd Knaub, Robert F Sidonio Jr
Stay updated on the latest scientific advances on bleeding disorders with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications